Q2 2020 PDS Biotechnology Corp Earnings Call Transcript
Greetings and welcome to PDS Biotechnologies Second Quarter 2020 Financial Results. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Deanne Randolph, Investor Relations.
Good morning, and welcome to PDS BioTechnologyâs Second Quarter 2020 Earnings Conference Call and Audio webcast. With me today are Dr. Frank Bedu-Addo, Chief Executive Officer; Dr. Lauren Wood, Chief Medical Officer; and Michael King, Interim Chief Financial Officer.
Earlier this morning, PDS Biotech issued a press release announcing financial results for the 3 months ended June 30, 2020. We encourage everyone to read today's press release as well as PDS Biotech's quarterly report on Form 10-Q, which will be filed with the SEC this afternoon. The company's press release is available on PDS Biotech's website at pdsbiotech.com, and the quarterly report will be posted later today.
In addition, this conference call is being
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |